NCT05170802View on ClinicalTrials.gov

Pancreatic Cancer & Surgical Resection

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

December 20, 2017

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Pancreas Cancer
Interventions
OTHER

NanoKnife procedure

clinical data regarding use of the NanoKnife system intraoperatively (via laparotomy) to ablate the pancreatic tumors per the treating physicians discretion will be collected.

Trial Locations (1)

75203

RECRUITING

Liver Institute of Methodist Dallas Medical Center, Dallas

All Listed Sponsors
lead

Methodist Health System

OTHER